Product Information |
|
Registration Number |
BR-1461
|
Generic Name |
Ocrelizumab
|
Brand Name |
Ocrevus
|
Dosage Strength |
300 mg/10 ml (30 mg/ml)
|
Dosage Form |
oncentrate for Solution for
Intravenous Infusion
|
Classification |
Prescription Drug (RX)
|
Packaging |
15 mL-capacity Type I colorless glass vial with a 20 gray rubber stopper crimped with a 20 aluminium seal fitted with a plastic green flip-off cap x 10 mL- net content (Box of 1's)
|
Pharmacologic Category |
Selective Immunosuppresant
|
Manufacturer |
F. Hoffmann-La Roche Ltd.
|
Country of Origin |
Switzerland
|
Trader |
|
Importer |
Roche (Philippines), Inc.
|
Distributor |
|
Application Type |
Monitored Release
|
Issuance Date |
22 December 2023
|
Expiry Date |
22 December 2028
|